Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.2.2
Commitments and Contingencies (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 30, 2020
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Product Liability Contingency [Line Items]              
Labor and Related Expense       $ 76,087      
Accrued expenses   $ 200,000   200,000   $ 224,949  
Research and Development Expense   2,207,913 $ 2,578,016 5,950,616 $ 7,449,869    
Repayments of Related Party Debt           800,000  
Development fees $ 1,000,000.0            
Payment for fees $ 775,000            
Houston Pharmaceuticals [Member]              
Product Liability Contingency [Line Items]              
Cost of Goods and Services Sold       41,075 385,000    
WPD Product Supply Agreement [Member]              
Product Liability Contingency [Line Items]              
Product held at third party depot   655,000   655,000      
WPD Product Supply Agreement [Member] | Upfront Payment [Member]              
Product Liability Contingency [Line Items]              
Due from Other Related Parties, Current   131,073   131,073      
WPD Product Supply Agreement [Member] | Pass Thru Costs [Member]              
Product Liability Contingency [Line Items]              
Due from Other Related Parties, Current   262,145   262,145      
Mr Hsu Scientific Advisory Board [Member]              
Product Liability Contingency [Line Items]              
Accrued expenses   $ 82,984   82,984      
Houston Pharm [Member] | Technology Rights Agreement [Member]              
Product Liability Contingency [Line Items]              
Royalty Income, Nonoperating       262,500 262,500    
WPD Pharmaceuticals [Member] | Upfront Payment [Member]              
Product Liability Contingency [Line Items]              
Other Nonoperating Income       393,182      
UTMDACC [Member] | Patent And Technology License Agr [Member]              
Product Liability Contingency [Line Items]              
License fee       49,607 $ 22,902    
UTMDACC [Member] | Sponsored Research Agreement [Member]              
Product Liability Contingency [Line Items]              
License fee             $ 334,000
Research and Development Expense             $ 400,000
WPD [Member] | Development Agreement [Member]              
Product Liability Contingency [Line Items]              
Development fees       $ 225,000      
Climaco [Member]              
Product Liability Contingency [Line Items]              
Salary and wages           525,000  
Silberman [Member]              
Product Liability Contingency [Line Items]              
Salary and wages           200,000  
Picker [Member]              
Product Liability Contingency [Line Items]              
Salary and wages           115,000  
Downs [Member]              
Product Liability Contingency [Line Items]              
Salary and wages           $ 340,000